The aim of this study was to determine the outcome of venous conduits used in living donor
liver transplantation (LDLT). We analyzed the portal vein complications in 66 LDLT recipients …

• Twenty-eight patients received orthotopic liver transplants for malignant disease between
February 1, 1984, and December 31, 1989. Preoperative diagnoses included hepatocellular …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and is
considered an aggressive tumor with mean survival estimated between 6 and 20 months. …

Background The outcomes of kidney transplantation and immunosuppression in people
infected with human immunodeficiency virus (HIV) are incompletely understood. Methods We …

Background and aims Golgi protein 73 (GP73) as a potential serum marker for hepatocellular
carcinoma (HCC) has not been validated in large cohort studies. Furthermore, its …

Hypothesis The appropriate surgical treatment of patients with colorectal cancer who are
found on initial presentation to have stage IV disease is controversial. With presumed limited …

Objective To assess the long-term incidence of venous complications, including portal vein
and hepatic vein stenoses, in both whole cadaveric and reduced-size cadaveric and living …

Six hundred sixty-six patients received 792 liver transplants between February 1, 1984 and
September 30, 1991. Biliary reconstruction was by choledochocholedochostomy (CDCD) …

To the Editor: Polyomavirus type BK nephropathy is an aggressively destructive disease
occurring in up to 8 percent of patients with renal allografts, 1 , 2 with rates of graft loss within …

Objective: To examine the outcome of technical variant liver transplant techniques relative
to whole organ liver transplantation in pediatric liver transplant recipients. Background: …